By Maydeen Merino | December 27, 2023
"The FTC will continue endeavoring to faithfully discharge our statutory obligation and protect the American public from unlawful mergers," said Lina Khan, the commission's chair.
National Law Journal | Analysis|News
By Abigail Adcox | December 27, 2023
While law firms in D.C. may have been more cautious with hiring, sustained demand for regulatory and enforcement practices have also had a positive effect on firms' profits.
By Marianna Wharry | December 21, 2023
In a blog post for Google, Wilson White, vice president of government affairs and public policy, wrote that the tech company is pleased with the results of the case. His post maintains that that settlement will "[build] on Android's choice and flexibility, [maintain] strong security protections, [retain] Google's ability to compete with other OS makers and [will] invest in the Android ecosystem for users and developers."
By Amanda O'Brien | December 20, 2023
The combination of Philadelphia-based Jefferson Health and Allentown Pennsylvania-based Lehigh Valley Health would host 30 hospitals and more than 62,000 employees spread across Pennsylvania and southern New Jersey.
By Maydeen Merino | December 19, 2023
FTC alleged purchase would have resulted in higher healthcare prices due to reduced competition.
By Maydeen Merino | December 18, 2023
"Fair, open, competitive markets have been essential to America's dynamic, thriving economy, and policing unlawful mergers is our front line of defense against harmful corporate consolidation," FTC Chair Lina Khan said.
By Ross Todd | December 15, 2023
Representing Epic Games, Gary Bornstein, Yonatan Even and Lauren Moskowitz of Cravath, Swaine & Moore convinced federal jurors in San Francisco that Google has an illegal monopoly on Android app distribution and in-app payments.
By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
New York Law Journal | Analysis
By Karen Hoffman Lent and Kenneth Schwartz | December 11, 2023
Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
By ALM Staff | December 11, 2023
This suit was surfaced by Law.com Radar. Read the complaint here.
Presented by BigVoodoo
Consulting Magazine identifies the best firms to work for in the consulting profession.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
The New Jersey Law Revision Commission, an independent legislative commission (N.J.S. 1:12A-1 et seq.), seeks a NJ-licensed atty in good sta...
The Federal Election Commission (FEC) is looking for a passionate and dedicated individual with extensive litigation experience as well as o...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...